Table 4 Medication at discharge and 12 months according to gender
| Â | At discharge | At 12 months* | ||||
|---|---|---|---|---|---|---|
| Â | Women | Men | p value | Women | Men | p value |
(n = 253) | (n = 795) | (n = 97) | (n = 375) | |||
ASS | 91% | 94% | 0.05 | 56% | 65% | 0.07 |
Clopidogrel | 88% | 93% | 0.02 | 31% | 40% | 0.10 |
Anticoagulation | 10% | 9% | 0.80 | 8% | 5% | 0.20. |
Triple therapy | 8% | 8% | 0.69 | 0% | 2% | 0.20. |
Beta-Blocker | 84% | 90% | <0.01 | 51% | 61% | 0.06 |
ACE inhibitor | 76% | 79% | 0.18 | 50% | 58% | 0.15 |
Lipid lowering drug | 71% | 84% | <0.01 | 53% | 61% | 0.14 |